Literature DB >> 9496464

Does glycogen depletion play an important role in ischemic preconditioning?

K Yabe1, S Takeo.   

Abstract

The present study was undertaken to determine whether or not tissue glycogen depletion prior to ischemia, and subsequent attenuation of tissue lactate accumulation during ischemia, correlates with postischemic functional recovery of the preconditioned heart. Isolated rat hearts were subjected to 40-min ischemia and 30-min reperfusion. Preconditioning with 5-min ischemia and 5-min reperfusion reduced the preischemic glycogen and postischemic lactate levels of the heart to 60.5 +/- 5.6% and 66.9 +/- 7.7% respectively, of values in non-preconditioned hearts (n = 6), and improved the recovery of the rate-pressure product (RPP) of the ischemic/reperfused heart (87.0 +/- 5.8% versus 25.2 +/- 4.5% of the initial value for the non-preconditioned group, n = 8). Treatment with polymyxin B (50 microM) abolished the preconditioning-induced postischemic recovery of the RPP. Treatment of the non-preconditioned heart with phorbol 12-myristate 13-acetate (15 pmol/5 min) resulted in an improvement in the postischemic recovery of RPP. Neither of these treatments affected the preischemic glycogen and postischemic lactate levels. The results suggest that preischemic glycogen depletion and subsequent attenuation of ischemic lactate accumulation do not play a major role in the preconditioning-induced protection against postischemic contractile dysfunction in perfused rat hearts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9496464     DOI: 10.1007/BF02767131

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  18 in total

1.  Myocardial glycogen depletion cannot explain the cardioprotective effects of ischemic preconditioning in the rat heart.

Authors:  G K Asimakis
Journal:  J Mol Cell Cardiol       Date:  1996-03       Impact factor: 5.000

2.  Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode.

Authors:  C E Murry; V J Richard; K A Reimer; R B Jennings
Journal:  Circ Res       Date:  1990-04       Impact factor: 17.367

3.  Polymyxin B, a protein kinase C inhibitor, abolishes preconditioning-induced protection against contractile dysfunction in the isolated blood perfused rat heart.

Authors:  A C Cave; C S Apstein
Journal:  J Mol Cell Cardiol       Date:  1996-05       Impact factor: 5.000

4.  Beta-adrenoceptor stimulation-mediated preconditioning-like cardioprotection in perfused rat hearts.

Authors:  Y Nasa; K Yabe; S Takeo
Journal:  J Cardiovasc Pharmacol       Date:  1997-04       Impact factor: 3.105

5.  Role of intracellular Na+ in Ca2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Possible involvement of H+-Na+ and Na+-Ca2+ exchange.

Authors:  M Tani; J R Neely
Journal:  Circ Res       Date:  1989-10       Impact factor: 17.367

6.  Preconditioning protects ischemic rabbit heart by protein kinase C activation.

Authors:  K Ytrehus; Y Liu; J M Downey
Journal:  Am J Physiol       Date:  1994-03

7.  Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha 1-adrenergic mechanism.

Authors:  A Banerjee; C Locke-Winter; K B Rogers; M B Mitchell; E C Brew; C B Cairns; D D Bensard; A H Harken
Journal:  Circ Res       Date:  1993-10       Impact factor: 17.367

8.  Transient beta adrenergic stimulation can precondition the rat heart against postischaemic contractile dysfunction.

Authors:  G K Asimakis; K Inners-McBride; V R Conti; C J Yang
Journal:  Cardiovasc Res       Date:  1994-11       Impact factor: 10.787

9.  Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved.

Authors:  H R Cross; L H Opie; G K Radda; K Clarke
Journal:  Circ Res       Date:  1996-03       Impact factor: 17.367

10.  Ischemic preconditioning protects against infarction in rat heart.

Authors:  Y Liu; J M Downey
Journal:  Am J Physiol       Date:  1992-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.